Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.

scientific article published on 28 April 2009

Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2008-2446
P698PubMed publication ID19401376
P5875ResearchGate publication ID24376303

P50authorSilvia ColucciQ37829968
Maria GranoQ37829977
Giacomina BrunettiQ40380152
Maria F. FaienzaQ47504141
Luciano CavalloQ57374836
P2093author name stringLucia Giordani
Giovanni Carlo Del Vecchio
Massimo D'Amore
Maria Ciccarelli
Laura Piacente
Livia Albanese
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)2269-2276
P577publication date2009-04-28
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleOsteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.
P478volume94

Reverse relations

cites work (P2860)
Q43007771Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin
Q57809044An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases
Q46284598Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS.
Q30478264Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase
Q35592362Bone-immune cell crosstalk: bone diseases.
Q38099517Causes, mechanisms and management of paediatric osteoporosis
Q38406386Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations
Q37056309Cross-talk between T cells and osteoclasts in bone resorption
Q57984974Evaluation of impact of steroid replacement treatment on bone health in children with 21-hydroxylase deficiency
Q64118749Experience in the Adaptive Immunity Impacts Bone Homeostasis, Remodeling, and Healing
Q26821908Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency
Q54276622High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.
Q41921500Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
Q64119225Metabolic Bone Disease of Prematurity: Diagnosis and Management
Q47638169Monoclonal antibodies for treating osteoporosis
Q41980849Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia
Q27026535Osteoporosis and obesity: Role of Wnt pathway in human and murine models
Q37402046Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review
Q38568957Peripheral Blood Mononuclear Cells Spontaneous Osteoclastogenesis: Mechanisms Driving the Process and Clinical Relevance in Skeletal Disease
Q36914237Postmenopausal osteoporosis: the role of immune system cells
Q34073420Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children.
Q35617495The "love hormone" oxytocin regulates the loss and gain of the fat-bone relationship
Q37052226The Interplay between the bone and the immune system
Q53563222The evaluation of bone metabolism in children with renal transplantation.
Q58327145Treatment of osteoporosis in children with glucocorticoid-treated diseases

Search more.